 Connection
Yuki Fujiwara to Female
This is a "connection" page, showing publications Yuki Fujiwara has written about Female.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.215 |
|
|
|
-
Komohara Y, Kurotaki D, Tsukamoto H, Miyasato Y, Yano H, Pan C, Yamamoto Y, Fujiwara Y. Involvement of protumor macrophages in breast cancer progression and characterization of macrophage phenotypes. Cancer Sci. 2023 Jun; 114(6):2220-2229.
Score: 0.027
-
Fujiwara Y, Kiyota N, Tsurushima K, Yoshitomi M, Horlad H, Ikeda T, Nohara T, Takeya M, Nagai R. Tomatidine, a tomato sapogenol, ameliorates hyperlipidemia and atherosclerosis in apoE-deficient mice by inhibiting acyl-CoA:cholesterol acyl-transferase (ACAT). J Agric Food Chem. 2012 Mar 14; 60(10):2472-9.
Score: 0.012
-
Yamada H, Yamada R, Komohara Y, Pan C, Yoshii D, Yano H, Matsubara E, Shinchi Y, Tsukamoto H, Fujiwara Y, Ikeda K, Suzuki M. Integrative analysis of T cell subset-specific ICOS expression and tumor HLA class I/II expression in lung adenocarcinoma: implications for their interaction and clinical outcome. Cancer Immunol Immunother. 2026 Feb 28; 75(3).
Score: 0.008
-
Hossen F, Kouwaki T, Fujiwara Y, Tsutsuki H, Zhang T, Guo C, Rahman A, Komohara Y, Oshiumi H, Sawa T. Therapeutic Efficacy of the Supersulfide Donor NAC-S2 in Influenza Virus Pneumonia via Suppression of Excessive Inflammatory Responses. Microbiol Immunol. 2026 Mar; 70(3):148-159.
Score: 0.008
-
Sakaida N, Yamada R, Arima K, Yamashita K, Hanada N, Yoshii D, Fujiwara Y, Nakashita C, Shimoda S, Iwatsuki M, Komohara Y. Relationship between nutritional indicators and clinicopathological factors, including immune cell densities in the tumor microenvironment, in patients with colorectal cancer. Med Mol Morphol. 2026 Jun; 59(2):113-123.
Score: 0.008
-
Adawy A, Yoshii D, Hirao H, Komohara Y, Fujiwara Y, Tomita M, Honda M, Han J, Liu Y, Yamada S, Yamamoto M, Hiyama E, Hibi T. Identification of CD7 as a novel biomarker of embryonal hepatoblastoma. Pediatr Surg Int. 2025 Dec 04; 42(1):30.
Score: 0.008
-
Ishida H, Rodriguez Franco S, Franklin O, Fujiwara Y, Khomiak A, Balmaceda NB, Pellegrini R, Mungo B, Schulick RD, Del Chiaro M. Neoadjuvant Therapy for Invasive Intraductal Papillary Mucinous Neoplasms: A Comparative Study With Pancreatic Ductal Adenocarcinoma. Ann Surg Oncol. 2026 Mar; 33(3):2620-2631.
Score: 0.008
-
Yamada H, Yano H, Matsubara E, Zhao S, Shinchi Y, Pan C, Koga T, Fujino K, Fujiwara Y, Ikeda K, Komohara Y, Suzuki M. The expression of PD-1 ligands in the immune microenvironment was altered in TTF-1-negative lung adenocarcinoma. Hum Cell. 2025 Aug 18; 38(5):146.
Score: 0.008
-
Tagayasu Y, Yamada R, Kanemitsu K, Kondo Y, Fujiwara Y, Tanizaki T, Itoyama R, Kitano Y, Hayashi H, Komohara Y, Iwatsuki M. Increased Infiltration of Tissue-Resident Memory T Cells Predicts a Good Response to Anti-PD-L1 Immunotherapy in Extrahepatic Cholangiocarcinoma. Pathobiology. 2026; 93(1):1-11.
Score: 0.008
-
Saisuwan K, Boonnate P, Goto H, Nakagawa R, Abe M, Hirabayashi K, Fujiwara Y, Kikuta K, Okada S. Establishment and characterization of TK-DDCS1: a novel IDH1 mutated dedifferentiated chondrosarcoma cell line. Hum Cell. 2025 Jun 03; 38(4):116.
Score: 0.008
-
Fukuda R, Fujiwara Y, Maeda H, Pan C, Minayoshi Y, Yano H, Mizuta Y, Takano M, Yamada R, Saito Y, Hirata K, Imoto S, Yamasaki K, Oniki K, Saruwatari J, Otagiri M, Watanabe H, Komohara Y, Maruyama T. Lymph node macrophage-targeted interferon alpha boosts anticancer immune responses by regulating CD169-positive phenotype of macrophages. Mol Cancer. 2025 May 03; 24(1):132.
Score: 0.008
-
Yokoi M, Murakami K, Yaguchi T, Chamoto K, Ozasa H, Yoshida H, Shirakashi M, Ito K, Komohara Y, Fujiwara Y, Yano H, Ogimoto T, Hira D, Terada T, Hirai T, Tsukamoto H. ICOS+CD4+ T cells define a high susceptibility to anti-PD-1 therapy-induced lung pathogenesis. JCI Insight. 2025 05 22; 10(10).
Score: 0.008
-
Yamada R, Arima K, Yano H, Fujiwara Y, Yamashita K, Kanemitsu K, Hanada N, Yasunaga JI, Iwatsuki M, Mikami Y, Komohara Y. Impact of HTLV-1 infection on clinicopathological characteristics and tumour immune microenvironment in colorectal cancer. Virchows Arch. 2025 Oct; 487(4):853-863.
Score: 0.008
-
Matsuzaki H, Kai K, Komohara Y, Yano H, Pan C, Fujiwara Y, Yamada R, Iwauchi A, Fukasawa N, Tanaka T, Shimoda M, Watanabe H, Maruyama T, Takeo T, Mikami Y, Mukasa A. Abnormal Vessels Potentially Accelerate Glioblastoma Proliferation by Inducing the Protumor Activation of Macrophages. Cancer Sci. 2025 Apr; 116(4):897-909.
Score: 0.008
-
Ezaki A, Yano H, Pan C, Fujiwara Y, Anami T, Ibe Y, Ozaki Y, Nishizawa H, Motoshima T, Yatsuda J, Watanabe H, Maruyama T, Takeo T, Kamba T, Komohara Y. Immunohistochemical Analysis of a1-Acid Glycoprotein and Tumor Associated Macrophages in Clear Cell Renal Cell Carcinoma. Cancer Genomics Proteomics. 2025 Jan-Feb; 22(1):103-111.
Score: 0.008
-
Nishitsuji K, Mito R, Ikezaki M, Yano H, Fujiwara Y, Matsubara E, Nishikawa T, Ihara Y, Uchimura K, Iwahashi N, Sakagami T, Suzuki M, Komohara Y. Impacts of cytoplasmic p53 aggregates on the prognosis and the transcriptome in lung squamous cell carcinoma. Cancer Sci. 2024 Sep; 115(9):2947-2960.
Score: 0.007
-
Sonokawa T, Fujiwara Y, Pan C, Komohara Y, Usuda J. Enhanced systemic antitumor efficacy of PD-1/PD-L1 blockade with immunological response induced by photodynamic therapy. Thorac Cancer. 2024 06; 15(18):1429-1436.
Score: 0.007
-
Kanemitsu K, Yamada R, Pan C, Tsukamoto H, Yano H, Shiota T, Fujiwara Y, Miyamoto Y, Mikami Y, Baba H, Komohara Y. Age-associated reduction of sinus macrophages in human mesenteric lymph nodes. J Clin Exp Hematop. 2024 Jun 27; 64(2):79-85.
Score: 0.007
-
Matsubara E, Shinchi Y, Komohara Y, Yano H, Pan C, Fujiwara Y, Ikeda K, Suzuki M. PD-L2 overexpression on tumor-associated macrophages is one of the predictors for better prognosis in lung adenocarcinoma. Med Mol Morphol. 2023 Dec; 56(4):250-256.
Score: 0.007
-
Yonemitsu K, Pan C, Fujiwara Y, Miyasato Y, Shiota T, Yano H, Hosaka S, Tamada K, Yamamoto Y, Komohara Y. GM-CSF derived from the inflammatory microenvironment potentially enhanced PD-L1 expression on tumor-associated macrophages in human breast cancer. Sci Rep. 2022 07 14; 12(1):12007.
Score: 0.006
-
Kosaka A, Ishibashi K, Nagato T, Kitamura H, Fujiwara Y, Yasuda S, Nagata M, Harabuchi S, Hayashi R, Yajima Y, Ohara K, Kumai T, Aoki N, Komohara Y, Oikawa K, Harabuchi Y, Kitada M, Kobayashi H, Ohkuri T. CD47 blockade enhances the efficacy of intratumoral STING-targeting therapy by activating phagocytes. J Exp Med. 2021 11 01; 218(11).
Score: 0.006
-
Yonemitsu K, Miyasato Y, Shiota T, Shinchi Y, Fujiwara Y, Hosaka S, Yamamoto Y, Komohara Y. Soluble Factors Involved in Cancer Cell-Macrophage Interaction Promote Breast Cancer Growth. Anticancer Res. 2021 Sep; 41(9):4249-4258.
Score: 0.006
-
Matsubara E, Komohara Y, Shinchi Y, Mito R, Fujiwara Y, Ikeda K, Shima T, Shimoda M, Kanai Y, Sakagami T, Suzuki M. CD163-positive cancer cells are a predictor of a worse clinical course in lung adenocarcinoma. Pathol Int. 2021 Oct; 71(10):666-673.
Score: 0.006
-
Shiraishi D, Fujiwara Y, Horlad H, Saito Y, Iriki T, Tsuboki J, Cheng P, Nakagata N, Mizuta H, Bekki H, Nakashima Y, Oda Y, Takeya M, Komohara Y. CD163 Is Required for Protumoral Activation of Macrophages in Human and Murine Sarcoma. Cancer Res. 2018 06 15; 78(12):3255-3266.
Score: 0.005
-
Tsuboki J, Fujiwara Y, Horlad H, Shiraishi D, Nohara T, Tayama S, Motohara T, Saito Y, Ikeda T, Takaishi K, Tashiro H, Yonemoto Y, Katabuchi H, Takeya M, Komohara Y. Onionin A inhibits ovarian cancer progression by suppressing cancer cell proliferation and the protumour function of macrophages. Sci Rep. 2016 07 12; 6:29588.
Score: 0.004
-
Ma C, Komohara Y, Ohnishi K, Shimoji T, Kuwahara N, Sakumura Y, Matsuishi K, Fujiwara Y, Motoshima T, Takahashi W, Yamada S, Kitada S, Fujimoto N, Nakayama T, Eto M, Takeya M. Infiltration of tumor-associated macrophages is involved in CD44 expression in clear cell renal cell carcinoma. Cancer Sci. 2016 May; 107(5):700-7.
Score: 0.004
-
Saito Y, Ohnishi K, Miyashita A, Nakahara S, Fujiwara Y, Horlad H, Motoshima T, Fukushima S, Jinnin M, Ihn H, Takeya M, Komohara Y. Prognostic Significance of CD169+ Lymph Node Sinus Macrophages in Patients with Malignant Melanoma. Cancer Immunol Res. 2015 Dec; 3(12):1356-63.
Score: 0.004
-
Komohara Y, Hasita H, Ohnishi K, Fujiwara Y, Suzu S, Eto M, Takeya M. Macrophage infiltration and its prognostic relevance in clear cell renal cell carcinoma. Cancer Sci. 2011 Jul; 102(7):1424-31.
Score: 0.003
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|